• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PI3K/PTEN/AKT/mTOR 通路在肝癌侵袭转移中的作用:与 MMP-9 的关系。

Involvement of PI3K/PTEN/AKT/mTOR pathway in invasion and metastasis in hepatocellular carcinoma: Association with MMP-9.

机构信息

Department of Hepatobiliary Surgery , The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.

出版信息

Hepatol Res. 2009 Feb;39(2):177-86. doi: 10.1111/j.1872-034X.2008.00449.x.

DOI:10.1111/j.1872-034X.2008.00449.x
PMID:19208038
Abstract

AIM

To investigate the status of Phosphatidylinositol 3-kinase (PI3K)/PTEN/AKT/mammalian target of rapamycin (mTOR) pathway and its correlation with clinicopathological features and matrix metalloproteinase-2, -9 (MMP-2, 9) in human hepatocellular carcinoma (HCC).

METHODS

PTEN, Phosphorylated AKT (p-AKT), Phosphorylated mTOR (p-mTOR), MMP-2, MMP-9 and Ki-67 expression levels were evaluated by immunohistochemistry on tissue microarrays containing 200 HCCs with paired adjacent non-cancerous liver tissues. PTEN, MMP-2 and MMP-9 mRNA levels were determined by real-time RT-PCR in 36 HCCs. The relationships between PI3K/PTEN/AKT/mTOR pathway and clinicopathological factors and MMP-2, 9 were analyzed in HCC.

RESULTS

In HCC, PTEN loss and overexpression of p-AKT and p-mTOR were associated with tumor grade, intrahepatic metastasis, vascular invasion, TNM stage and high Ki-67 labeling index (P < 0.05). PTEN loss was correlated with p-AKT, p-mTOR and MMP-9 overexpression. Furthermore, PTEN and MMP-2, 9 mRNA levels were down-regulated and up-regulated in HCC compared with paired non-cancerous liver tissues, respectively (P < 0.01). PTEN, MMP-2 and MMP-9 mRNA levels were correlated with tumor stage and metastasis. There was an inverse correlation between PTEN and MMP-9 mRNA expression. However, PI3K/PTEN/AKT/mTOR pathway was not correlated with MMP-2.

CONCLUSIONS

PI3K/PTEN/AKT/mTOR pathway, which is activated in HCC, is involved in invasion and metastasis through up-regulating MMP-9 in HCC.

摘要

目的

研究磷脂酰肌醇 3-激酶(PI3K)/PTEN/AKT/哺乳动物雷帕霉素靶蛋白(mTOR)通路在人肝细胞癌(HCC)中的状态及其与临床病理特征的关系,并探讨其与基质金属蛋白酶-2(MMP-2)、-9(MMP-9)的相关性。

方法

采用组织微阵列免疫组化法检测 200 例 HCC 及其配对癌旁非肿瘤组织中 PTEN、磷酸化 AKT(p-AKT)、磷酸化 mTOR(p-mTOR)、MMP-2、MMP-9 和 Ki-67 的表达水平,实时 RT-PCR 法检测 36 例 HCC 中 PTEN、MMP-2 和 MMP-9 的 mRNA 水平。分析 HCC 中 PI3K/PTEN/AKT/mTOR 通路与临床病理因素及 MMP-2、9 的关系。

结果

在 HCC 中,PTEN 缺失和 p-AKT、p-mTOR 的过度表达与肿瘤分级、肝内转移、血管侵犯、TNM 分期和高 Ki-67 标记指数有关(P<0.05)。PTEN 缺失与 p-AKT、p-mTOR 和 MMP-9 的过度表达相关。此外,与配对癌旁非肿瘤组织相比,HCC 中 PTEN 和 MMP-2、9 的 mRNA 水平分别下调和上调(P<0.01)。PTEN、MMP-2 和 MMP-9 的 mRNA 水平与肿瘤分期和转移相关。PTEN 和 MMP-9 mRNA 表达呈负相关,而 PI3K/PTEN/AKT/mTOR 通路与 MMP-2 无关。

结论

在 HCC 中激活的 PI3K/PTEN/AKT/mTOR 通路通过上调 HCC 中的 MMP-9 参与侵袭和转移。

相似文献

1
Involvement of PI3K/PTEN/AKT/mTOR pathway in invasion and metastasis in hepatocellular carcinoma: Association with MMP-9.PI3K/PTEN/AKT/mTOR 通路在肝癌侵袭转移中的作用:与 MMP-9 的关系。
Hepatol Res. 2009 Feb;39(2):177-86. doi: 10.1111/j.1872-034X.2008.00449.x.
2
Alpha1-ACT Functions as a Tumour Suppressor in Hepatocellular Carcinoma by Inhibiting the PI3K/AKT/mTOR Signalling Pathway via Activation of PTEN.α1-ACT通过激活PTEN抑制PI3K/AKT/mTOR信号通路,在肝细胞癌中发挥肿瘤抑制作用。
Cell Physiol Biochem. 2017;41(6):2289-2306. doi: 10.1159/000475648. Epub 2017 Apr 26.
3
Overexpression of Bmi-1 contributes to the invasion and metastasis of hepatocellular carcinoma by increasing the expression of matrix metalloproteinase (MMP)‑2, MMP-9 and vascular endothelial growth factor via the PTEN/PI3K/Akt pathway.Bmi-1 的过表达通过 PTEN/PI3K/Akt 通路增加基质金属蛋白酶(MMP)-2、MMP-9 和血管内皮生长因子的表达,促进肝癌的侵袭和转移。
Int J Oncol. 2013 Sep;43(3):793-802. doi: 10.3892/ijo.2013.1992. Epub 2013 Jun 26.
4
Associations of components of PTEN/AKT/mTOR pathway with cancer stem cell markers and prognostic value of these biomarkers in hepatocellular carcinoma.PTEN/AKT/mTOR通路成分与癌症干细胞标志物的关联以及这些生物标志物在肝细胞癌中的预后价值
Hepatol Res. 2016 Dec;46(13):1380-1391. doi: 10.1111/hepr.12687. Epub 2016 Apr 8.
5
PTEN inhibits the migration and invasion of HepG2 cells by coordinately decreasing MMP expression via the PI3K/Akt pathway.PTEN 通过协调降低 MMP 表达来抑制 HepG2 细胞的迁移和侵袭,途径是 PI3K/Akt 通路。
Oncol Rep. 2010 Jun;23(6):1593-600. doi: 10.3892/or_00000800.
6
A blockade of PD-L1 produced antitumor and antimetastatic effects in an orthotopic mouse pancreatic cancer model via the PI3K/Akt/mTOR signaling pathway.在原位小鼠胰腺癌模型中,PD-L1阻断通过PI3K/Akt/mTOR信号通路产生抗肿瘤和抗转移作用。
Onco Targets Ther. 2017 Apr 12;10:2115-2126. doi: 10.2147/OTT.S130481. eCollection 2017.
7
Down-regulation of LncRNA NR027113 inhibits cell proliferation and metastasis via PTEN/PI3K/AKT signaling pathway in hepatocellular carcinoma.LncRNA NR027113 的下调通过 PTEN/PI3K/AKT 信号通路抑制肝癌细胞的增殖和转移。
Eur Rev Med Pharmacol Sci. 2018 Nov;22(21):7222-7232. doi: 10.26355/eurrev_201811_16256.
8
Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.微小RNA-16对肝癌细胞增殖、侵袭和转移的抑制作用。
Int J Mol Med. 2015 Dec;36(6):1713-9. doi: 10.3892/ijmm.2015.2379. Epub 2015 Oct 16.
9
A detailed immunohistochemical analysis of the PI3K/AKT/mTOR pathway in lung cancer: correlation with PIK3CA, AKT1, K-RAS or PTEN mutational status and clinicopathological features.肺癌中 PI3K/AKT/mTOR 通路的详细免疫组化分析:与 PIK3CA、AKT1、K-RAS 或 PTEN 基因突变状态及临床病理特征的相关性。
Oncol Rep. 2013 Aug;30(2):623-36. doi: 10.3892/or.2013.2512. Epub 2013 May 31.
10
DAPT suppresses proliferation and migration of hepatocellular carcinoma by regulating the extracellular matrix and inhibiting the Hes1/PTEN/AKT/mTOR signaling pathway.双联抗血小板治疗(DAPT)通过调节细胞外基质和抑制Hes1/PTEN/AKT/mTOR信号通路来抑制肝细胞癌的增殖和迁移。
J Gastrointest Oncol. 2021 Jun;12(3):1101-1116. doi: 10.21037/jgo-21-235.

引用本文的文献

1
Urolithin A suppressed osteosarcoma cell migration and invasion via targeting MMPs and AKT1.尿石素A通过靶向基质金属蛋白酶(MMPs)和蛋白激酶B1(AKT1)抑制骨肉瘤细胞的迁移和侵袭。
Sci Rep. 2025 Jul 17;15(1):25941. doi: 10.1038/s41598-025-11804-2.
2
Extracellular vesicles in atherosclerosis cardiovascular disease: emerging roles and mechanisms.动脉粥样硬化性心血管疾病中的细胞外囊泡:新出现的作用和机制
Front Cardiovasc Med. 2025 Jun 24;12:1611557. doi: 10.3389/fcvm.2025.1611557. eCollection 2025.
3
Macrophage-related inflammatory responses to degradation products of biodegradable molybdenum implants.
巨噬细胞对可生物降解钼植入物降解产物的相关炎症反应。
Mater Today Bio. 2025 Jan 23;31:101519. doi: 10.1016/j.mtbio.2025.101519. eCollection 2025 Apr.
4
Evaluation of Genes and Molecular Pathways Common between Diffuse Large B-cell Lymphoma (DLBCL) and Systemic Lupus Erythematosus (SLE): A Systems Biology Approach.弥漫性大B细胞淋巴瘤(DLBCL)与系统性红斑狼疮(SLE)共同的基因和分子通路评估:一种系统生物学方法
Med J Islam Repub Iran. 2024 Nov 6;38:129. doi: 10.47176/mjiri.38.129. eCollection 2024.
5
Unveiling the Role of Mechanistic Target of Rapamycin Kinase (MTOR) Signaling in Cancer Progression and the Emergence of MTOR Inhibitors as Therapeutic Strategies.揭示雷帕霉素激酶机制靶点(MTOR)信号在癌症进展中的作用以及MTOR抑制剂作为治疗策略的出现。
ACS Pharmacol Transl Sci. 2024 Nov 27;7(12):3758-3779. doi: 10.1021/acsptsci.4c00530. eCollection 2024 Dec 13.
6
Alpha lipoic acid diminishes migration and invasion in hepatocellular carcinoma cells through an AMPK-p53 axis.硫辛酸通过 AMPK-p53 轴减少肝癌细胞的迁移和侵袭。
Sci Rep. 2024 Sep 11;14(1):21275. doi: 10.1038/s41598-024-72309-y.
7
FGA influences invasion and metastasis of hepatocellular carcinoma through the PI3K/AKT pathway.FGA 通过 PI3K/AKT 通路影响肝癌的侵袭和转移。
Aging (Albany NY). 2024 Jul 9;16(19):12806-12819. doi: 10.18632/aging.206011.
8
Loss of monopolar spindle-binding protein 3B expression promotes colorectal cancer invasiveness by activation of target of rapamycin kinase/autophagy signaling.单极纺锤体结合蛋白3B表达缺失通过激活雷帕霉素激酶靶点/自噬信号通路促进结直肠癌侵袭。
World J Gastroenterol. 2024 Jul 14;30(26):3229-3246. doi: 10.3748/wjg.v30.i26.3229.
9
Pentagalloyl Glucose (PGG) Exhibits Anti-Cancer Activity against Aggressive Prostate Cancer by Modulating the ROR1 Mediated AKT-GSK3β Pathway.五没食子酰葡萄糖(PGG)通过调节 ROR1 介导的 AKT-GSK3β 通路发挥抗侵袭性前列腺癌活性。
Int J Mol Sci. 2024 Jun 26;25(13):7003. doi: 10.3390/ijms25137003.
10
MicroRNAs targeted mTOR as therapeutic agents to improve radiotherapy outcome.微小RNA靶向mTOR作为治疗药物以改善放疗效果。
Cancer Cell Int. 2024 Jul 4;24(1):233. doi: 10.1186/s12935-024-03420-3.